References
- Buykx P, Dietze P, Ritter A, et al. Characteristics of medication overdose presentations to the ED: how do they differ from illicit drug overdose and self-harm cases? Emergency Med J. 2010;27:499–503.
- Griffin E, Corcoran P, Cassidy L, et al. Characteristics of hospital-treated intentional drug overdose in Ireland and Northern Ireland. BMJ Open. 2014;4:e005557
- Schillie SF, Shehab N, Thomas KE, et al. Medication overdoses leading to emergency department visits among children. Am J Prev Med. 2009;37:181–187.
- Hoegberg LCG, Gude AB. Techniques used to prevent gastrointestinal absorption. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, editors. Goldfrank’s toxicologic emergencies. 10th ed. New York: McGraw-Hill Companies, Inc.; 2015. p. 83–96.
- Hendrickson RG. Acetaminophen. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, editors. Goldfrank’s toxicologic emergencies. 10th ed. New York: McGraw-Hill Education; 2015. p. 447–464.
- Jang DH, DeRoos FJ. Calcium channel blockers. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, editors. Goldfrank’s toxicologic emergencies. 10th ed. New York: McGraw-Hill Education; 2015. p. 843–855.
- Juurlink D, Antipsychotics. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, editors. Goldfrank’s toxicologic emergencies. 10th ed. New York: McGraw-Hill Education; 2015. p. 960–971.
- Nokhodchi A, Raja S, Patel P, et al. The role of oral controlled release matrix tablets in drug delivery systems. BioImpacts 2012;2:175–187.
- Livshits Z, Sampson BA, Howland MA, et al. Retained drugs in the gastrointestinal tracts of deceased victims of oral drug overdose. Clin Toxicol (Philadelphia, PA). 2015;53:113–118.
- Miyauchi M, Hayashida M, Yokota H. Evaluation of residual toxic substances in the stomach using upper gastrointestinal endoscopy for management of patients with oral drug overdose on admission: a prospective, observational study. Medicine 2015;94:e463.
- Rauber-Luthy C, Hofer KE, Bodmer M. Gastric pharmacobezoars in quetiapine extended-release overdose: a case series. Clin Toxicol (Philadelphia, PA). 2013;51:937–940.
- Chiew AL, Isbister GK, Kirby KA, et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol (Philadelphia, PA). 2017;55:1055–1065.
- Salmonson H, Sjoberg G, Brogren J. The standard treatment protocol for paracetamol poisoning may be inadequate following overdose with modified release formulation: a pharmacokinetic and clinical analysis of 53 cases. Clin Toxicol (Philadelphia, PA). 2018;56:63–68.
- Mortensen KE, Munkholm J, Dalhoff KP, et al. Oesophageal obstruction from a pharmacobezoar resulting in death. Basic Clin Pharmacol Toxicol. 2017;120:213–216.
- Simulated gastric fluid. European Pharmacopoeia. 9th ed. Strasbourg: . Council of Europe; 2016.
- Magdalan J, Zawadzki M, Słoka T, et al. Suicidal overdose with relapsing clomipramine concentrations due to a large gastric pharmacobezoar. Forensic Sci Int. 2013;229:e19–e22.
- Wells CD, Luckritz TC, Rady MY, et al. Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine. Pharmacotherapy 2006;26:1802–1805.
- Hojer J, Salmonson H, Sjoberg G, et al. Overdosering av paracetamol med modifierad frisattning okar – Etablerad behandlingsregim med N-acetylcystein otillracklig – Giftinformationscentralen ger ut nya behandlingsrad. Läkartidningen 2016;113:D93C.
- Bernstein G, Jehle D, Bernaski E, et al. Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation. Ann Emerg Med. 1992;21:1388–1390.
- Cereda JM, Scott J, Quigley EM. Endoscopic removal of pharmacobezoar of slow release theophylline. Br Med J (Clin Res Ed). 1986;293:1143.
- Liaw GW, Chen CH, Tseng YJ, et al. Pharmacobezoar of the esophagus. Clin Toxicol (Phila). 2011;49:348–349.
- Lung D, Cuevas C, Zaid U, et al. Venlafaxine pharmacobezoar causing intestinal ischemia requiring emergent hemicolectomy. J Med Toxicol. 2011;7:232–235.
- Khera G, Lord R, Grey K, et al. An unusual case of right iliac fossa mass – pharmacobezoar mimicking inflammatory bowel disease. Colorect Dis. 2007;10:95–96.
- Harikumar R, Kunnel P, Sunilraj R. Dissolution of pharmacobezoar using carbonated beverage. Ind J Gastroenterol: Off J Ind Soc Gastroenterol. 2008;27:245–246.
- Ogawa K, Kamimura K, Mizuno K, et al. The combination therapy of dissolution using carbonated liquid and endoscopic procedure for bezoars: pragmatical and clinical review. Gastroenterol Res Practice. 2016;2016:1. Article ID 7456242.
- Regaño S, Trugeda M, Gutierrez G, et al. Gastric bezoar dissolution with oral Coca-Cola® intake. GastroHepcom. 2009. Available from: http://www.gastrohep.com/classcases/classcases.asp?id=47 (Accessed 05 April 2018).
- Briggs AL, Deal LL. Endoscopic removal of pharmacobezoar in case of intentional potassium overdose. J Emerg Med. 2014;46:351–354.
- Djogovic D, Hudson D, Jacka M. Gastric bezoar following venlafaxine overdose. Clin Toxicol (Philadelphia, PA). 2007;45:735.
- Guillermo PTJ, Carlos PHJ, Ivonne BAM, et al. Extended release potassium salts overdose and endoscopic removal of a pharmacobezoar: a case report. Toxicol Rep. 2014;1:209–213.
- Hojer J, Personne M. Endoscopic removal of slow release clomipramine bezoars in two cases of acute poisoning. Clin Toxicol (Philadelphia, PA). 2008;46:317–319.
- Johnson J, Williams K, Banner W. Jr,. Adolescent with prolonged toxidrome. Clin Toxicol (Philadelphia, PA). 2017;55:364–365.
- Saeki S, Shimoda T, Sakai H, et al. Successful treatment of theophylline toxicity by upper gastrointestinal endoscopy. Respir Med. 2003;97:734–735.
- Schwerk C, Schulz M, Schwerk N, et al. Etilefrinhydrochloride tablet ingestion: successful therapy by endoscopic removal of tablet conglomerate. Klin Padiatr. 2009;221:93–96.
- Smith WDF. Endoscopic removal of a pharmacobezoar of slow release theophylline. British Med J (Clin Res Ed). 1987;294:125.
- Song KY, Choi BJ, Kim SN, et al. Laparoscopic removal of gastric bezoar. Surg Laparoscopy, Endoscopy & Percutaneous Tech. 2007;17:42–44.
- Ng HW, Tse ML, Lau FL, et al. Endoscopic removal of iron bezoar following acute overdose. Clin Toxicol (Philadelphia, PA). 2008;46:913–915.
- Mmeje C, Bouchard A, Heppell J. Image of the month. Pharmacobezoar: a rare complication after ileal pouch-anal anastomosis for ulcerative colitis. Clin Gastroenterol and Hepatol: The Off Clin Practice J Am Gastroenterol Ass. 2010;8:A28.
- Shigekawa Y, Kobayashi Y, Higashiguchi T, et al. Rectal obstruction by a giant pharmacobezoar composed of magnesium oxide: report of a case. Surg Today. 2010;40:972–974.
- Ginther DN, Kriegler S, Kanthan R, et al. Unexpected intra-operative diagnosis of a large cystic phaeochromocytoma and secondary nifedipine pharmacobezoar. S Afr J Surg. 2012;50:98–99.
- Landsman I, Bricker JT, Reid BS, et al. Emergency gastrotomy: treatment of choice for iron bezoar. J Pediatr Surg. 1987;22:184–185.
- Taylor JR, Streetman DS, Castle SS. Medication bezoars: a literature review and report of a case. Ann Pharmacother. 1998;32:940–946.
- Danish Medicines Agency. Summary of Product Characteristics: Isoptin Retard 240 mg, Tegretol Retard 200 mg, Pinex Retard 500 mg, Panodil 500 mg [2018 Jun 27]. Available from: www.produktresume.dk
- European Medicines Agency. Seroquel XR – Article 6(13) – Annex I, II, III, IV [2018 Jun 27]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Seroquel_XR_6/WC500099193.pdf